MAPK3 and type 2 diabetes mellitus: Therefore, our results suggest that increased β-arrestin-1 levels may be associated with the onset of affective symptoms due to T2DM following desensitization of GPCR signaling and GPCR-associated effects on ERK1/2 and CREB (see Introduction).